Math Can Predict How Cancer Cells Evolve

Applied mathematics can be a powerful tool in helping predict the genesis and evolution of different types of cancers, a study from the University of Waterloo has found. The study used a form of mathematical analysis called evolutionary dynamics to look at how malignant mutations evolve in both stem and non-stem cells in colorectal and [...]

By |2018-01-22T16:00:42+00:00January 22nd, 2018|Oncology|0 Comments

New Avenue for Attacking Prostrate Cancer Cells

In most cases, prostate cancer is cured by surgical removal of the tumour and / or by radiotherapy. However, 20 per cent of patients will need treatment to remove tumour cells, but this treatment ceases to be effective after two or three years and the cancer develops further. Once this stage of the disease has [...]

By |2018-01-22T15:59:45+00:00January 22nd, 2018|Oncology|0 Comments

One-in-Five Young Colon Cancer Patients Have Genetic Link

As doctors grapple with increasing rates of colorectal cancers in young people, new research from the University of Michigan may offer some insight into how the disease developed and how to prevent further cancers. Researchers found that 20 per cent of young people diagnosed with colorectal cancer have an inherited genetic abnormality that predisposes to [...]

By |2018-01-22T15:58:29+00:00January 22nd, 2018|Oncology|0 Comments

Sensor Developed for the Most Important Human Cancer Gene

A molecular smoke alert has now been developed by Dresden researchers for the TP53 gene, the most important human cancer gene. The alert goes on if the TP53 gene is mutated in cells. The molecular smoke detector works like a TP53 sensor, which monitors the correct function of the gene. A non-functional TP53 gene is [...]

By |2017-11-27T13:43:37+00:00November 27th, 2017|Oncology|0 Comments

Electronic Nose Could Achieve Early Diagnosis for Pancreatic Cancer

In research published in the latest edition of the UEG Journal, scientists in Finland demonstrated that there’s variance in the volatile compounds found in the urine of pancreatic cancer patients to that of healthy controls. Research was then undertaken to assess whether Field Asymmetric Ion Mobility Spectrometry (FAIMS) technology could effectively differentiate between pancreatic cancer [...]

By |2017-11-27T13:42:37+00:00November 27th, 2017|Oncology|0 Comments

New Therapy for Rare Cancer that Targets the Young

After years of rigorous research, a team of scientists has identified the genetic engine that drives a rare form of liver cancer. The findings offer prime targets for drugs to treat the usually lethal disease, fibrolamellar hepatocellular carcinoma (FL-HCC), which mainly strikes adolescents and young adults. Sanford Simon, who conducted the research as head of [...]

By |2017-11-27T13:41:40+00:00November 27th, 2017|Oncology|0 Comments

Three New Lung Cancer Genetic Biomarkers Discovere

Both environmental and genetic risk factors contribute to development of lung cancer. Tobacco smoking is the most well-known environmental risk factor associated with lung cancer. A Dartmouth research team led by Yafang Li, PhD, has conducted a study to display that gene-smoking interactions play important roles in the etiology of lung cancer. In their study, [...]

By |2017-11-07T12:30:56+00:00November 7th, 2017|Oncology|0 Comments

New Clues to Mechanisms Behind Breast Cancer

72 new genetic variants that contribute to the risk of developing breast cancer have been identified by a major international collaboration involving hundreds of researchers worldwide. Of these variants, reported in the journals, Nature and Nature Genetics, 65 are common variants that predispose to breast cancer and a further seven predispose specifically to oestrogen-receptor negative [...]

By |2017-11-06T11:27:27+00:00November 6th, 2017|Oncology|0 Comments

Pharmacist Finds Protein that Drives Tumour Growth in Gallbladder Cancer

Patients with gallbladder cancer often show few or no symptoms for long periods of time. As a result, the tumours are only detected at a late stage of the disease when treatment is often no longer possible. Working in collaboration with pathologists at the University of Magdeburg, Sonja M Kessler, a research pharmacist in the [...]

By |2017-11-06T11:26:35+00:00November 6th, 2017|Oncology|0 Comments

New Blood Test Detects Early Resistance to BRCA-Targeting Drugs

Scientists have developed a new highly sensitive blood test to deliver precision medicine to women with BRCA mutations who have breast or ovarian cancer. The test detects changes in the BRCA1 or BRCA2 genes that mean the cancer will no longer respond to platinum chemotherapy or targeted drugs called PARP inhibitors. In future, it could [...]

By |2017-11-06T11:24:42+00:00November 6th, 2017|Oncology|0 Comments